Stock Analiz

Autolus Therapeutics plc (AUTL) stock forecast and price target

Price $1.17 · data as of November 13, 2026

12-month price target

Average target$8.36
Upside / downside+614.7%
Analysts8
ConsensusStrong buy
Low $5.00Average $8.36High $11.00

Gold marker: average target · white marker: today’s price ($1.17)

Analyst ratings

Strong buy 1Buy 8Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.80+26.1%$152M
Next fiscal year
ends December 31, 2027
$-0.57+29.1%$197M
Quarter after
ends December 31, 2026
$-0.18+48.0%$42M

Consensus of the analysts covering Autolus Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Frequently asked questions

What is the Autolus Therapeutics stock price target?

The average 12-month target from 8 analysts is $8.36, 614.7% above the current price of $1.17 Targets range from $5.00 to $11.00.

Is Autolus Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 8 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Autolus Therapeutics expected to earn?

Analysts expect EPS of $-0.80 for the fiscal year ending December 31, 2026 and $-0.57 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.